
About Charco Neurotech
Charco Neurotech is a Healthcare company based in Cambridge (United Kingdom) founded in 2019. Non-invasive wearable devices for Parkinsons management are developed. It operates in the Healthcare and Technology sectors. Charco Neurotech has raised $17.25 million across 6 funding rounds from investors including Imperial College London, Royal College of Art and Amadeus Capital Partners. The company has 22 employees. Charco Neurotech was last valued at $13.71 million in June 2024. Its website charconeurotech.com draws about 13 thousand monthly visits. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is CHARCO NEUROTECH LTD. Its competitors include PD Neurotechnology and GaitQ; 2 of its 2 listed competitors have raised funding.
Company details
Developer of a non-invasive wearable device for people with Parkinsons. The company has developed a CUE1 device that utilizes pulsed cueing and vibrotactile stimulation to the peripheral nervous system that helps in the reductions of slowness and stiffness resulting in improved movement. The device can act as a medication reminder and helps in symptom tracking and monitoring. The platform also offers an app that is integrated with the device and allows users to instruct the device when to remind them to take their medicine.
- Headquarters Cambridge, United Kingdom
- Employees 22
- Stage Minicorn
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website charconeurotech.com
- Social LinkedIn X Facebook
- Legal Name Charco Neurotech Ltd
- Date of Incorporation 03 Jun, 2019
- Jurisdiction CAMBRIDGE, UNITED KINGDOM
- Total Equity Funding$17.25M (USD)
in 6 rounds
- Latest Funding Round$695.85K (USD), Seed
Jun 2024
- InvestorsImperial College London
& 8 more
- Employee Count22
Funding Insights of Charco Neurotech
Charco Neurotech has successfully raised a total of $17.25M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $695.85 thousand completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $17.25M
- Total Rounds 6
- Last Round Seed — $695,849
- Investors Count 9
All 6 funding rounds of Charco Neurotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2024 | $695,849 | Seed | $13.71M | – | – |
| Feb 2024 | $5.53M | Seed | $12.96M | – | – |
| Nov 2021 | $10M | Seed | – | Amadeus Capital, Parkwalk | |
| Feb 2021 | $744,913 | Seed | – | Imperial College London | |
| Jun 2020 | $276,714 | Seed | – | Royal College of Art | – |
| Jun 2019 | Grant | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Jun 2024 | $13.71M | •••••••• |
| Feb 2024 | $12.96M | •••••••• |
Last known valuation $13.71M (Jun 2024). 9 investors in total: 9 institutional.
Investors in Charco Neurotech
Charco Neurotech has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Imperial College London, Royal College of Art and Amadeus Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage deep technology investments are made by Amadeus Capital. | amadeuscapital.com | London, United Kingdom | ||
Tech companies are invested in by Parkwalk venture capital firm. | parkwalkadvisors.com | London, United Kingdom | ||
Seed and Early stage VC firm investing in Japan | ut-ec.co.jp | Tokyo, Japan | ||
| cristagalli.com | ||||
A global venture platform focused on biotech and healthcare startups is operated. | mintventures.bio | Seoul, South Korea | ||
Early-stage companies are funded and supported by Oxbridge Angels. | oxbridgeangels.com | London, United Kingdom | ||
Accelerator and incubator programme for art and design projects | 1837 | rca.ac.uk | London, United Kingdom | |
Multiple courses and degrees are offered across diversified academic streams. | 1907 | imperial.ac.uk | London, United Kingdom | |
| medtechsuperconnector.com |
Investor details for Charco Neurotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Charco Neurotech
5 people are tracked at Charco Neurotech (2 in leadership, 3 in team); the tracked headcount is 22.
| Name | Role | Group |
|---|---|---|
Angie Nauful | General Manager | Leadership |
Andrew Mullen | Chief Executive Officer | Leadership |
Keith Kicheol Park | EVP / R&D LEAD | Team |
Charlie Alvarez | Chairman | Team |
Dahee Han | Creative Lead | Team |
Complete people profiles for Charco Neurotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Charco Neurotech
4 dated milestones of Charco Neurotech across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Charco Neurotech is founded.
- Funding First funding round.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $696K.
Competitors of Charco Neurotech
Charco Neurotech has 2 listed competitors in our database, 2 of them funded. They include PD Neurotechnology and GaitQ.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pdneurotechnology.com | 2015 | London, United Kingdom | $93.34M | 32 | A wearable device is developed to monitor Parkinson's movement disorders. | |
| gaitq.com | 2020 | Oxford, United Kingdom | $857,801 | 5 | Developer of a device to prevent gait freeze for Parkinson's patients |
Detailed competitors of Charco Neurotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Charco Neurotech
The website of Charco Neurotech (charconeurotech.com) receives about 13.4K visits a month.
- Monthly visits13.4K
▲ 36.5% vs previous month
Websites whose visitors overlap most with Charco Neurotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
symbyxbiome.com | symbyxbiome.com | 100% | #1,053,715 | – | |
| parkinsons.org.uk | 97% | #163,700 | View details | ||
trisys.co.uk | trisys.co.uk | 26% | #13,487,738 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Charco Neurotech
Complete news archive for Charco Neurotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Charco Neurotech
Charco Neurotech was founded in 2019.
Charco Neurotech is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Charco Neurotech is a funded company, having raised a total of $17.25M across 6 funding rounds to date.
Charco Neurotech has 22 employees.
Developer of a non-invasive wearable device for people with Parkinsons. The company has developed a CUE1 device that utilizes pulsed cueing and vibrotactile stimulation to the peripheral nervous system that helps in the reductions of slowness and stiffness resulting in improved movement. The device can act as a medication reminder and helps in symptom tracking and monitoring. The platform also offers an app that is integrated with the device and allows users to instruct the device when to remind them to take their medicine.
Charco Neurotech's top competitors include PD Neurotechnology and GaitQ.
Charco Neurotech has 9 investors. Key investors include Imperial College London, Royal College of Art, Amadeus Capital Partners, Parkwalk, and UT-EC Japan.
The valuation of Charco Neurotech is $13.71M as of Jun 2024.
Charco Neurotech operates through Charco Neurotech Ltd.
